HCPCS code lookup

HCPCS Level II

J2779

Injection, ranibizumab, via intravitreal implant (susvimo), 0.1 mg

Ask Rivvi

Code
J2779
Description
Injection, ranibizumab, via intravitreal implant (susvimo), 0.1 mg

CMS HCPCS quarterly update

NDC crosswalk

  • 50242-0078-12 Susvimo, Genentech, Inc.. Billable units per 11-digit NDC: 100.
  • 50242-0078-55 Susvimo, Genentech, Inc.. Billable units per 11-digit NDC: 100.

Source: CMS ASP NDC-HCPCS crosswalk, effective October 1, 2026 through December 31, 2026.

Try it on your own data today.

Free to start. Most teams are using it the same day.